Dental Biomaterials-Pipeline Review, 2015

Dental Biomaterials-Pipeline Review, 2015


  • Products Id :- GDME0093EPD
  • |
  • Pages: 80
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Dental Biomaterials-Pipeline Review, 2015

GlobalData's Medical Devices sector report, "Dental Biomaterials-Pipeline Review, 2015" provides an overview of Dental Biomaterials currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dental Biomaterials pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Dental Biomaterials under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Dental Biomaterials and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons To Buy

The report enables you to

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Dental Biomaterials under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 6

2 Introduction 7

2.1 Dental Biomaterials Overview 7

3 Products under Development 8

3.1 Dental Biomaterials-Pipeline Products by Stage of Development 8

3.2 Dental Biomaterials-Pipeline Products by Segment 9

3.3 Dental Biomaterials-Pipeline Products by Territory 10

3.4 Dental Biomaterials-Pipeline Products by Regulatory Path 11

3.5 Dental Biomaterials-Pipeline Products by Estimated Approval Date 12

3.6 Dental Biomaterials-Ongoing Clinical Trials 13

4 Dental Biomaterials-Pipeline Products under Development by Companies 14

4.1 Dental Biomaterials Companies-Pipeline Products by Stage of Development 14

4.2 Dental Biomaterials-Pipeline Products by Stage of Development 16

5 Dental Biomaterials Companies and Product Overview 18

5.1 3-D Matrix, Ltd. Company Overview 18

5.1.1 3-D Matrix, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 18

5.2 Advanced Medical Solutions Group plc Company Overview 20

5.2.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 20

5.3 botiss dental GmbH Company Overview 28

5.3.1 botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview 28

5.4 CollPlant Ltd. Company Overview 34

5.4.1 CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview 34

5.5 CoreBone Ltd. Company Overview 35

5.5.1 CoreBone Ltd. Pipeline Products & Ongoing Clinical Trials Overview 35

5.6 Harvard University Company Overview 36

5.6.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 36

5.7 Histocell S.L. Company Overview 37

5.7.1 Histocell S.L. Pipeline Products & Ongoing Clinical Trials Overview 37

5.8 Ironwood Material Science Inc Company Overview 38

5.8.1 Ironwood Material Science Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.9 Lacerta Technologies GmbH Company Overview 39

5.9.1 Lacerta Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 39

5.10 Maxigen Biotech Inc. Company Overview 40

5.10.1 Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

5.11 Medisse BV Company Overview 43

5.11.1 Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 43

5.12 Medtronic plc Company Overview 44

5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 44

5.13 Meta Biomed Co., Ltd. Company Overview 47

5.13.1 Meta Biomed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47

5.14 NDSU Research Foundation Company Overview 51

5.14.1 NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 51

5.15 Noraker Company Overview 52

5.15.1 Noraker Pipeline Products & Ongoing Clinical Trials Overview 52

5.16 NovaBone Products, LLC. Company Overview 54

5.16.1 NovaBone Products, LLC. Pipeline Products & Ongoing Clinical Trials Overview 54

5.17 Novatissue SAS Company Overview 55

5.17.1 Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview 55

5.18 REGENECURE, Ltd. Company Overview 56

5.18.1 REGENECURE, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56

5.19 Straumann Holding AG Company Overview 59

5.19.1 Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview 59

5.20 SurgaColl Technologies Ltd Company Overview 62

5.20.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

5.21 The University of Queensland Company Overview 63

5.21.1 The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 63

5.22 Tigran Technologies AB Company Overview 64

5.22.1 Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview 64

5.23 Universitat Politecnica de Catalunya Company Overview 65

5.23.1 Universitat Politecnica de Catalunya Pipeline Products & Ongoing Clinical Trials Overview 65

5.24 University of Strasbourg Company Overview 67

5.24.1 University of Strasbourg Pipeline Products & Ongoing Clinical Trials Overview 67

6 Dental Biomaterials- Recent Developments 68

7 Appendix 77

7.1 Methodology 77

7.2 About GlobalData 79

7.3 Contact Us 80

7.4 Disclaimer 80

1.2 List of Figures

Figure 1: Dental Biomaterials-Pipeline Products by Stage of Development 8

Figure 2: Dental Biomaterials-Pipeline Products by Segment 9

Figure 3: Dental Biomaterials-Pipeline Products by Territory 10

Figure 4: Dental Biomaterials-Pipeline Products by Regulatory Path 11

Figure 5: Dental Biomaterials-Pipeline Products by Estimated Approval Date 12

Figure 6: Dental Biomaterials-Ongoing Clinical Trials 13

1.1 List of Tables

Table 1: Dental Biomaterials-Pipeline Products by Stage of Development 8

Table 2: Dental Biomaterials-Pipeline Products by Segment 9

Table 3: Dental Biomaterials-Pipeline Products by Territory 10

Table 4: Dental Biomaterials-Pipeline Products by Regulatory Path 11

Table 5: Dental Biomaterials-Pipeline Products by Estimated Approval Date 12

Table 6: Dental Biomaterials-Ongoing Clinical Trials 13

Table 7: Dental Biomaterials Companies-Pipeline Products by Stage of Development 14

Table 8: Dental Biomaterials-Pipeline Products by Stage of Development 16

Table 9: 3-D Matrix, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 18

Table 10: TDM-711-Product Status 19

Table 11: TDM-711-Product Description 19

Table 12: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 20

Table 13: PARASORB Cone-Product Status 21

Table 14: PARASORB Cone-Product Description 21

Table 15: PARASORB Cone Genta-Product Status 22

Table 16: PARASORB Cone Genta-Product Description 22

Table 17: PARASORB Fleece-Product Status 23

Table 18: PARASORB Fleece-Product Description 23

Table 19: PARASORB Fleece Genta HD-Product Status 24

Table 20: PARASORB Fleece Genta HD-Product Description 24

Table 21: PARASORB Fleece HD-Product Status 25

Table 22: PARASORB Fleece HD-Product Description 25

Table 23: PARASORB RESODONT-Product Status 26

Table 24: PARASORB RESODONT-Product Description 26

Table 25: PARASORB Sombrero-Product Status 27

Table 26: PARASORB Sombrero-Product Description 27

Table 27: botiss dental GmbH Pipeline Products & Ongoing Clinical Trials Overview 28

Table 28: cerabone-Product Status 29

Table 29: cerabone-Product Description 29

Table 30: maxresorb-Product Status 30

Table 31: maxresorb-Product Description 30

Table 32: maxresorb Inject-Product Status 31

Table 33: maxresorb Inject-Product Description 31

Table 34: mucoderm-Product Status 32

Table 35: mucoderm-Product Description 32

Table 36: perossal-Product Status 33

Table 37: perossal-Product Description 33

Table 38: CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview 34

Table 39: VergenixAR-Product Status 34

Table 40: VergenixAR-Product Description 34

Table 41: CoreBone Ltd. Pipeline Products & Ongoing Clinical Trials Overview 35

Table 42: Dental Bone Graft-Product Status 35

Table 43: Dental Bone Graft-Product Description 35

Table 44: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 36

Table 45: Artificial Teeth-Product Status 36

Table 46: Artificial Teeth-Product Description 36

Table 47: Histocell S.L. Pipeline Products & Ongoing Clinical Trials Overview 37

Table 48: Neofibrin-Product Status 37

Table 49: Neofibrin-Product Description 37

Table 50: Ironwood Material Science Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Table 51: GEMOSIL-Dental Implant-Product Status 38

Table 52: GEMOSIL-Dental Implant-Product Description 38

Table 53: Lacerta Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 39

Table 54: Albumin Bone Graft-Product Status 39

Table 55: Albumin Bone Graft-Product Description 39

Table 56: Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

Table 57: MaxiBone-Product Status 41

Table 58: MaxiBone-Product Description 41

Table 59: MaxiGuide-Product Status 42

Table 60: MaxiGuide-Product Description 42

Table 61: Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 43

Table 62: Dental Membrane-Product Status 43

Table 63: Dental Membrane-Product Description 43

Table 64: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 44

Table 65: MD05-P Bone Graft Substitute Material-Product Status 45

Table 66: MD05-P Bone Graft Substitute Material-Product Description 45

Table 67: MD08 Injectable Paste-Product Status 46

Table 68: MD08 Injectable Paste-Product Description 46

Table 69: Meta Biomed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47

Table 70: Biocompatible Sealer-Product Status 48

Table 71: Biocompatible Sealer-Product Description 48

Table 72: Endodontic Sealer-Product Status 49

Table 73: Endodontic Sealer-Product Description 49

Table 74: Root Canal Sealer-Product Status 50

Table 75: Root Canal Sealer-Product Description 50

Table 76: NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 51

Table 77: Synthetic Mandible-Product Status 51

Table 78: Synthetic Mandible-Product Description 51

Table 79: Noraker Pipeline Products & Ongoing Clinical Trials Overview 52

Table 80: Bone Grafting Device-Dental Surgery-Product Status 52

Table 81: Bone Grafting Device-Dental Surgery-Product Description 52

Table 82: Self-Hardening Injectable Substitute-Dental Surgery-Product Status 53

Table 83: Self-Hardening Injectable Substitute-Dental Surgery-Product Description 53

Table 84: NovaBone Products, LLC. Pipeline Products & Ongoing Clinical Trials Overview 54

Table 85: Bioengineered Resorbable Bone Graft-Dental-Product Status 54

Table 86: Bioengineered Resorbable Bone Graft-Dental-Product Description 54

Table 87: Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview 55

Table 88: Dental NovaOss-Product Status 55

Table 89: Dental NovaOss-Product Description 55

Table 90: REGENECURE, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56

Table 91: Regenecure AMCA GBR Dental Membrane Implant-Product Status 56

Table 92: Regenecure AMCA GBR Dental Membrane Implant-Product Description 56

Table 93: REGENECURE, Ltd-Ongoing Clinical Trials Overview 57

Table 94: Regenecure AMCA GBR Dental Membrane Implant-Horizontal Guided Bone Regeneration for Dental Implants Using Synthetic Membrane (Regenecures' AMCA GBR Dental Membrane) a Prospective Controlled Study 58

Table 95: Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview 59

Table 96: Enhanced Bone Graft-Product Status 60

Table 97: Enhanced Bone Graft-Product Description 60

Table 98: Soft Tissue Control Implant-Product Status 61

Table 99: Soft Tissue Control Implant-Product Description 61

Table 100: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

Table 101: DentaColl-Product Status 62

Table 102: DentaColl-Product Description 62

Table 103: The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 63

Table 104: Dental Material-Product Status 63

Table 105: Dental Material-Product Description 63

Table 106: Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview 64

Table 107: Tigran Porous Titanium Granules-Alveolar Fillings-Product Status 64

Table 108: Tigran Porous Titanium Granules-Alveolar Fillings-Product Description 64

Table 109: Universitat Politecnica de Catalunya Pipeline Products & Ongoing Clinical Trials Overview 65

Table 110: Inorganic Dental Cement-Product Status 66

Table 111: Inorganic Dental Cement-Product Description 66

Table 112: University of Strasbourg Pipeline Products & Ongoing Clinical Trials Overview 67

Table 113: Nanostructured Biomaterial-Product Status 67

Table 114: Nanostructured Biomaterial-Product Description 67

Table 115: Glossary 78

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

3-D Matrix, Ltd.

Advanced Medical Solutions Group plc

botiss dental GmbH

CollPlant Ltd.

CoreBone Ltd.

Harvard University

Histocell S.L.

Ironwood Material Science Inc

Lacerta Technologies GmbH

Maxigen Biotech Inc.

Medisse BV

Medtronic plc

Meta Biomed Co., Ltd.

NDSU Research Foundation

Noraker

NovaBone Products, LLC.

Novatissue SAS

REGENECURE, Ltd.

Straumann Holding AG

SurgaColl Technologies Ltd

The University of Queensland

Tigran Technologies AB

Universitat Politecnica de Catalunya

University of Strasbourg

3-D Matrix, Ltd., TDM-711, Advanced Medical Solutions Group plc, PARASORB Cone, PARASORB Cone Genta, PARASORB Fleece, PARASORB Fleece Genta HD, PARASORB Fleece HD, PARASORB RESODONT, PARASORB Sombrero, botiss dental GmbH, cerabone, maxresorb, maxresorb Inject, mucoderm, perossal, CollPlant Ltd., VergenixAR, CoreBone Ltd., Dental Bone Graft, Harvard University, Artificial Teeth, Histocell S.L., Neofibrin, Ironwood Material Science Inc, GEMOSIL - Dental Implant, Lacerta Technologies GmbH, Albumin Bone Graft, Maxigen Biotech Inc., MaxiBone, Maxigen Biotech Inc., MaxiGuide, Medisse BV, Dental Membrane, Medtronic plc, MD05-P Bone Graft Substitute Material, MD08 Injectable Paste, Meta Biomed Co., Ltd., Biocompatible Sealer, Endodontic Sealer, Root Canal Sealer, NDSU Research Foundation, Synthetic Mandible, Noraker, Bone Grafting Device - Dental Surgery, Self-Hardening Injectable Substitute - Dental Surgery, NovaBone Products, LLC., Bioengineered Resorbable Bone Graft - Dental, Novatissue SAS, Dental NovaOss, REGENECURE, Ltd., Regenecure AMCA GBR Dental Membrane Implant, Straumann Holding AG, Enhanced Bone Graft, Soft Tissue Control Implant, SurgaColl Technologies Ltd, DentaColl, The University of Queensland, Dental Material, Tigran Technologies AB, Tigran Porous Titanium Granules - Alveolar Fillings, Universitat Politecnica de Catalunya, Inorganic Dental Cement, University of Strasbourg, Nanostructured Biomaterial

select a license

Single User License
USD 4000 INR 259040
Site License
USD 8000 INR 518080
Corporate User License
USD 12000 INR 777120

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com